GSB Wealth Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.59M | Sell |
23,009
-2,185
| -9% | -$151K | 0.39% | 80 |
|
|
2025
Q1 | $1.75M | Buy |
25,194
+800
| +3% | +$55.6K | 0.46% | 74 |
|
|
2024
Q4 | $2.1M | Buy |
24,394
+11,970
| +96% | +$1.03M | 0.54% | 64 |
|
|
2024
Q3 | $1.48M | Sell |
12,424
-1,204
| -9% | -$143K | 0.38% | 84 |
|
|
2024
Q2 | $1.95M | Buy |
13,628
+39
| +0.3% | +$5.57K | 0.53% | 65 |
|
|
2024
Q1 | $1.74M | Sell |
13,589
-634
| -4% | -$81.4K | 0.49% | 69 |
|
|
2023
Q4 | $1.47M | Buy |
14,223
+200
| +1% | +$20.7K | 0.45% | 75 |
|
|
2023
Q3 | $1.28M | Sell |
14,023
-1,323
| -9% | -$120K | 0.43% | 79 |
|
|
2023
Q2 | $1.24M | Buy |
15,346
+580
| +4% | +$46.9K | 0.4% | 83 |
|
|
2023
Q1 | $1.17M | Sell |
14,766
-2,296
| -13% | -$183K | 0.38% | 89 |
|
|
2022
Q4 | $1.15M | Sell |
17,062
-250
| -1% | -$16.9K | 0.41% | 89 |
|
|
2022
Q3 | $862K | Buy |
17,312
+32
| +0.2% | +$1.59K | 0.31% | 109 |
|
|
2022
Q2 | $963K | Sell |
17,280
-5,614
| -25% | -$313K | 0.33% | 106 |
|
|
2022
Q1 | $1.27M | Sell |
22,894
-2,150
| -9% | -$119K | 0.37% | 98 |
|
|
2021
Q4 | $1.4M | Buy |
25,044
+18,288
| +271% | +$1.02M | 0.4% | 88 |
|
|
2021
Q3 | $324K | Sell |
6,756
-19,640
| -74% | -$942K | 0.17% | 115 |
|
|
2021
Q2 | $1.11M | Buy |
26,396
+134
| +0.5% | +$5.62K | 0.34% | 99 |
|
|
2021
Q1 | $885K | Buy |
26,262
+19,506
| +289% | +$657K | 0.29% | 105 |
|
|
2020
Q4 | $236K | Hold |
6,756
| – | – | 1.06% | 42 |
|
|
2020
Q3 | $235K | Hold |
6,756
| – | – | 1.07% | 43 |
|
|
2020
Q2 | $221K | Hold |
6,756
| – | – | 1.23% | 40 |
|
|
2020
Q1 | $203K | Buy |
+6,756
| New | +$203K | 1.48% | 37 |
|